ID   STF1_RAT                Reviewed;         462 AA.
AC   P50569;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   24-JUL-2024, entry version 181.
DE   RecName: Full=Steroidogenic factor 1;
DE            Short=SF-1;
DE            Short=STF-1;
DE   AltName: Full=Adrenal 4-binding protein;
DE   AltName: Full=Fushi tarazu factor homolog 1;
DE   AltName: Full=Nuclear receptor subfamily 5 group A member 1;
DE   AltName: Full=Steroid hormone receptor Ad4BP;
GN   Name=Nr5a1; Synonyms=Ftzf1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=7706291; DOI=10.1074/jbc.270.13.7453;
RA   Nomura M.M.N., Smith J.;
RT   "An E box element is required for the expression of the ad4bp gene, a
RT   mammalian homologue of ftz-f1 gene, which is essential for adrenal and
RT   gonadal development.";
RL   J. Biol. Chem. 270:7453-7461(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 20-293.
RX   PubMed=8395654; DOI=10.1210/mend.7.6.8395654;
RA   Lynch J.P., Lala D.S., Peluso J.J., Luo W., Parker K.L., White B.A.;
RT   "Steroidogenic factor 1, an orphan nuclear receptor, regulates the
RT   expression of the rat aromatase gene in gonadal tissues.";
RL   Mol. Endocrinol. 7:776-786(1993).
CC   -!- FUNCTION: Transcriptional activator. Seems to be essential for sexual
CC       differentiation and formation of the primary steroidogenic tissues.
CC       Binds to the Ad4 site found in the promoter region of steroidogenic
CC       P450 genes such as CYP11A, CYP11B and CYP21B. Also regulates the
CC       AMH/Muellerian inhibiting substance gene as well as the AHCH and STAR
CC       genes. 5'-YCAAGGYC-3' and 5'-RRAGGTCA-3' are the consensus sequences
CC       for the recognition by NR5A1. The SFPQ-NONO-NR5A1 complex binds to the
CC       CYP17 promoter and regulates basal and cAMP-dependent transcriptional
CC       activity. Binds phosphatidylcholine and phospholipids with a
CC       phosphatidylinositol (PI) headgroup, in particular PI(3,4)P2 and
CC       PI(3,4,5)P3. Activated by the phosphorylation of NR5A1 by HIPK3 leading
CC       to increased steroidogenic gene expression upon cAMP signaling pathway
CC       stimulation (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Binds DNA as a monomer (By similarity). Part of a complex
CC       consisting of SFPQ, NONO and NR5A1. Interacts with NR0B2, NCOA2 and
CC       PPARGC1A. Interacts with DGKQ and CDK7. Binds to and activated by HIPK3
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- PTM: Acetylation stimulates the transcriptional activity.
CC       {ECO:0000250}.
CC   -!- PTM: Sumoylation reduces CDK7-mediated phosphorylation on Ser-203.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated on Ser-203 by CDK7. This phosphorylation promotes
CC       transcriptional activity (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR5
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D42156; BAA07722.1; -; Genomic_DNA.
DR   PIR; A56120; A56120.
DR   RefSeq; NP_001178028.1; NM_001191099.1.
DR   AlphaFoldDB; P50569; -.
DR   SMR; P50569; -.
DR   STRING; 10116.ENSRNOP00000017651; -.
DR   PhosphoSitePlus; P50569; -.
DR   PaxDb; 10116-ENSRNOP00000017651; -.
DR   Ensembl; ENSRNOT00000017651.4; ENSRNOP00000017651.1; ENSRNOG00000012682.7.
DR   Ensembl; ENSRNOT00055014442; ENSRNOP00055011557; ENSRNOG00055008558.
DR   Ensembl; ENSRNOT00060048106; ENSRNOP00060040032; ENSRNOG00060027725.
DR   Ensembl; ENSRNOT00065047350; ENSRNOP00065038836; ENSRNOG00065027467.
DR   GeneID; 83826; -.
DR   KEGG; rno:83826; -.
DR   UCSC; RGD:68350; rat.
DR   AGR; RGD:68350; -.
DR   CTD; 2516; -.
DR   RGD; 68350; Nr5a1.
DR   eggNOG; KOG4218; Eukaryota.
DR   GeneTree; ENSGT00940000153391; -.
DR   HOGENOM; CLU_011437_0_0_1; -.
DR   InParanoid; P50569; -.
DR   OMA; EVTCNNL; -.
DR   OrthoDB; 2968690at2759; -.
DR   PhylomeDB; P50569; -.
DR   TreeFam; TF350737; -.
DR   Reactome; R-RNO-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-RNO-4090294; SUMOylation of intracellular receptors.
DR   PRO; PR:P50569; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000012682; Expressed in ovary and 4 other cell types or tissues.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IMP:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0004879; F:nuclear receptor activity; ISO:RGD.
DR   GO; GO:0005543; F:phospholipid binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0001221; F:transcription coregulator binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030325; P:adrenal gland development; ISO:RGD.
DR   GO; GO:0097720; P:calcineurin-mediated signaling; IMP:RGD.
DR   GO; GO:0008585; P:female gonad development; IEP:RGD.
DR   GO; GO:0042445; P:hormone metabolic process; ISO:RGD.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IDA:RGD.
DR   GO; GO:0033327; P:Leydig cell differentiation; ISO:RGD.
DR   GO; GO:0001553; P:luteinization; ISO:RGD.
DR   GO; GO:0051457; P:maintenance of protein location in nucleus; ISO:RGD.
DR   GO; GO:0008584; P:male gonad development; ISS:UniProtKB.
DR   GO; GO:0030238; P:male sex determination; ISO:RGD.
DR   GO; GO:2000195; P:negative regulation of female gonad development; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:2000020; P:positive regulation of male gonad development; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0097210; P:response to gonadotropin-releasing hormone; IEP:RGD.
DR   GO; GO:0060008; P:Sertoli cell differentiation; ISO:RGD.
DR   GO; GO:0007530; P:sex determination; ISS:UniProtKB.
DR   GO; GO:0009888; P:tissue development; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IMP:RGD.
DR   CDD; cd07167; NR_DBD_Lrh-1_like; 1.
DR   CDD; cd07070; NR_LBD_SF-1; 1.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1.
DR   Gene3D; 1.10.565.10; Retinoid X Receptor; 1.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR016355; NR5-like.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR24086; NUCLEAR RECEPTOR SUBFAMILY 5 GROUP A; 1.
DR   PANTHER; PTHR24086:SF24; STEROIDOGENIC FACTOR 1; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PIRSF; PIRSF002530; Nuc_orph_FTZ-F1; 1.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1.
DR   SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   3: Inferred from homology;
KW   Acetylation; Activator; DNA-binding; Isopeptide bond; Lipid-binding;
KW   Metal-binding; Nucleus; Phosphoprotein; Receptor; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..462
FT                   /note="Steroidogenic factor 1"
FT                   /id="PRO_0000053734"
FT   DOMAIN          223..460
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        10..85
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         13..33
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         49..73
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          117..149
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        124..143
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         342
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phosphocholine"
FT                   /ligand_id="ChEBI:CHEBI:57643"
FT                   /evidence="ECO:0000250|UniProtKB:P33242"
FT   BINDING         437
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phosphocholine"
FT                   /ligand_id="ChEBI:CHEBI:57643"
FT                   /evidence="ECO:0000250|UniProtKB:P33242"
FT   BINDING         441
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phosphocholine"
FT                   /ligand_id="ChEBI:CHEBI:57643"
FT                   /evidence="ECO:0000250|UniProtKB:P33242"
FT   MOD_RES         34
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13285"
FT   MOD_RES         38
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13285"
FT   MOD_RES         72
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13285"
FT   MOD_RES         203
FT                   /note="Phosphoserine; by CDK7"
FT                   /evidence="ECO:0000250|UniProtKB:Q13285"
FT   CROSSLNK        119
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        194
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CONFLICT        150
FT                   /note="K -> R (in Ref. 2)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   462 AA;  52087 MW;  89963798A66FFE04 CRC64;
     MDYSYDEDLD ELCPVCGDKV SGYHYGLLTC ESCKGFFKRT VQNNKHYTCT ESQSCKIDKT
     QRKRCPFCRF QKCLTVGMRL EAVRADRMRG GRNKFGPMYK RDRALKQQKK AQIRANGFKL
     ETGPPMGVPP PPPPPPDYML PPSLHAPEPK ALVSGPPSGP LGDFGAPSLP MAVPGPHGPL
     AGYLYPAFSN RTIKSEYPEP YASPPQQPGP PYSYPEPFSG GPNVPELILQ LLQLEPEEDQ
     VRARIVGCLQ EPAKSRPDQP APFSLLCRMA DQTFISIVDW ARRCMVFKEL EVADQMTLLQ
     NCWSELLVLD HIYRQVQYGK EDSILLVTGQ EVELSTVAVQ AGSLLHSLVL RAQELVLQLH
     ALQLDRQEFV CLKFLILFSL DVKFLNNHSL VKDAQEKANA ALLDYTLCHY PHCGDKFQQL
     LLCLVEVRAL SMQAKEYLYH KHLGNEMPRN NLLIEMLQAK QT
//
